ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 376265 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 376265; 2) Community: the network communities that were significantly associated with the response to NSC 376265; 3) Molecule: the relationships between components within communities and NSC 376265; 4) MDR: the compounds that were significantly associated with the NSC 376265.

NSC Compound Enrichment Correlation
NSC 310547 Null 0.0220039422291538 0.45899143
NSC 175630 Toyocamycin, 6-amino- 0.0228506033927954 0.32241271
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0228506033927954 0.60815105
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0228506033927954 -0.030626107
NSC 352299 2-methylellpticinium 0.0228506033927954 -0.095145203
NSC 327993 Verrucarin A, 7'-deoxo-9,10-epoxy-9,10-dihydro-8-hydroxy-7'-(1-hydro ethyl)-, (8.beta.,9.beta.,10.beta.)- 0.0228506033927957 0.065537838
NSC 381866 BAFILOMYCIN DERIV. 0.0228506033927957 0.44652322
NSC 621326 Null 0.0228506033927957 0.29061594
NSC 666295 Null 0.0228506033927957 0.52196039
NSC 674278 Null 0.0228506033927957 -0.27533754
Total:50  Current:23    [First] [Prev] [Next] [Last]